In CAPS patients, gain-of-function mutation of NLRP3 leads to the aberrant inflammasome activation and increased IL-1β secretion, resulting in the systemic inflammation and disease systems. The gene discussed is IL1B; the disease is cryopyrin-associated periodic syndrome.